Trial intelligence / Profile preview

Veramyst in Allergic Conjunctivitis

NCT00891436Phase 4Completed

Sponsor
Rush University Medical Center
Start
Apr 2009
Primary completion
Jul 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of fluticasone propionate nasal spray in allergic conjunctivitis (AC), sponsored by Rush University Medical Center. Started Apr 2009; status: completed.

02

Drugs

fluticasone propionate nasal spray
03

Conditions

allergic conjunctivitis (AC)

Beyond the preview

Go deeper on NCT00891436.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00891436.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call